China-Australia Center for Translational Medicine
中澳转化医学研究中心

China

1 March 2020 - 28 February 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for China-Australia Center for Translational Medicine published between 1 March 2020 - 28 February 2021 which are tracked by the Nature Index.

Research collaboration: China-Australia Center for Translational Medicine is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
1 0.31

1 March 2020 - 28 February 2021

International vs. domestic collaboration by Share

  • 46.09% Domestic
  • 53.91% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (3 total)

  • China-Australia Center for Translational Medicine, China
  • Domestic institution
  1. Nanjing University (NJU), China (0.69)
    0.31
    0.38
  2. Chinese Academy of Sciences (CAS), China (0.42)
    0.31
    0.11
  3. Zhejiang University (ZJU), China (0.34)
    0.31
    0.04

Top 10 international collaborators by Share (4 total)

  • China-Australia Center for Translational Medicine, China
  • Foreign institution
  1. University of California, San Francisco (UCSF), United States of America (USA) (0.55)
    0.31
    0.24
  2. Cancer Trials Australia (CTA), Australia (0.38)
    0.31
    0.08
  3. The University of Melbourne (UniMelb), Australia (0.38)
    0.31
    0.08
  4. Walter and Eliza Hall Institute of Medical Research (WEHI), Australia (0.38)
    0.31
    0.08

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Participating institutions

China-Australia Center for Translational Medicine is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Return to institution outputs